Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Digital Therapeutics Market, by End Use
1.4.2 Global Digital Therapeutics Market, by Application
1.4.3 Global Digital Therapeutics Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Restraints:
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Business Expansions
3.2.4 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Mar – 2021, Mar) Leading Players
Chapter 4. Global Digital Therapeutics Market by End Use
4.1 Global Patients Market by Region
4.2 Global Providers Market by Region
4.3 Global Payers Market by Region
4.4 Global Employers Market by Region
4.5 Global Other End Use Market by Region
Chapter 5. Global Digital Therapeutics Market by Applications
5.1 Global Diabetes Applications Market by Region
5.2 Global CNS Disease Applications Market by Region
5.3 Global Respiratory Diseases Applications Market by Region
5.4 Global Smoking Cessation Applications Market by Region
5.5 Global Obesity Applications Market by Region
5.6 Global CVD Applications Market by Region
5.7 Global Other Applications Market by Region
Chapter 6. Global Digital Therapeutics Market by Region
6.1 North America Digital Therapeutics Market
6.1.1 North America Digital Therapeutics Market by End Use
6.1.1.1 North America Patients Market by Country
6.1.1.2 North America Providers Market by Country
6.1.1.3 North America Payers Market by Country
6.1.1.4 North America Employers Market by Country
6.1.1.5 North America Other End Use Market by Country
6.1.2 North America Digital Therapeutics Market by Applications
6.1.2.1 North America Diabetes Applications Market by Country
6.1.2.2 North America CNS Disease Applications Market by Country
6.1.2.3 North America Respiratory Diseases Applications Market by Country
6.1.2.4 North America Smoking Cessation Applications Market by Country
6.1.2.5 North America Obesity Applications Market by Country
6.1.2.6 North America CVD Applications Market by Country
6.1.2.7 North America Other Applications Market by Country
6.1.3 North America Digital Therapeutics Market by Country
6.1.3.1 US Digital Therapeutics Market
6.1.3.1.1 US Digital Therapeutics Market by End Use
6.1.3.1.2 US Digital Therapeutics Market by Applications
6.1.3.2 Canada Digital Therapeutics Market
6.1.3.2.1 Canada Digital Therapeutics Market by End Use
6.1.3.2.2 Canada Digital Therapeutics Market by Applications
6.1.3.3 Mexico Digital Therapeutics Market
6.1.3.3.1 Mexico Digital Therapeutics Market by End Use
6.1.3.3.2 Mexico Digital Therapeutics Market by Applications
6.1.3.4 Rest of North America Digital Therapeutics Market
6.1.3.4.1 Rest of North America Digital Therapeutics Market by End Use
6.1.3.4.2 Rest of North America Digital Therapeutics Market by Applications
6.2 Europe Digital Therapeutics Market
6.2.1 Europe Digital Therapeutics Market by End Use
6.2.1.1 Europe Patients Market by Country
6.2.1.2 Europe Providers Market by Country
6.2.1.3 Europe Payers Market by Country
6.2.1.4 Europe Employers Market by Country
6.2.1.5 Europe Other End Use Market by Country
6.2.2 Europe Digital Therapeutics Market by Applications
6.2.2.1 Europe Diabetes Applications Market by Country
6.2.2.2 Europe CNS Disease Applications Market by Country
6.2.2.3 Europe Respiratory Diseases Applications Market by Country
6.2.2.4 Europe Smoking Cessation Applications Market by Country
6.2.2.5 Europe Obesity Applications Market by Country
6.2.2.6 Europe CVD Applications Market by Country
6.2.2.7 Europe Other Applications Market by Country
6.2.3 Europe Digital Therapeutics Market by Country
6.2.3.1 Germany Digital Therapeutics Market
6.2.3.1.1 Germany Digital Therapeutics Market by End Use
6.2.3.1.2 Germany Digital Therapeutics Market by Applications
6.2.3.2 UK Digital Therapeutics Market
6.2.3.2.1 UK Digital Therapeutics Market by End Use
6.2.3.2.2 UK Digital Therapeutics Market by Applications
6.2.3.3 France Digital Therapeutics Market
6.2.3.3.1 France Digital Therapeutics Market by End Use
6.2.3.3.2 France Digital Therapeutics Market by Applications
6.2.3.4 Russia Digital Therapeutics Market
6.2.3.4.1 Russia Digital Therapeutics Market by End Use
6.2.3.4.2 Russia Digital Therapeutics Market by Applications
6.2.3.5 Spain Digital Therapeutics Market
6.2.3.5.1 Spain Digital Therapeutics Market by End Use
6.2.3.5.2 Spain Digital Therapeutics Market by Applications
6.2.3.6 Italy Digital Therapeutics Market
6.2.3.6.1 Italy Digital Therapeutics Market by End Use
6.2.3.6.2 Italy Digital Therapeutics Market by Applications
6.2.3.7 Rest of Europe Digital Therapeutics Market
6.2.3.7.1 Rest of Europe Digital Therapeutics Market by End Use
6.2.3.7.2 Rest of Europe Digital Therapeutics Market by Applications
6.3 Asia Pacific Digital Therapeutics Market
6.3.1 Asia Pacific Digital Therapeutics Market by End Use
6.3.1.1 Asia Pacific Patients Market by Country
6.3.1.2 Asia Pacific Providers Market by Country
6.3.1.3 Asia Pacific Payers Market by Country
6.3.1.4 Asia Pacific Employers Market by Country
6.3.1.5 Asia Pacific Other End Use Market by Country
6.3.2 Asia Pacific Digital Therapeutics Market by Applications
6.3.2.1 Asia Pacific Diabetes Applications Market by Country
6.3.2.2 Asia Pacific CNS Disease Applications Market by Country
6.3.2.3 Asia Pacific Respiratory Diseases Applications Market by Country
6.3.2.4 Asia Pacific Smoking Cessation Applications Market by Country
6.3.2.5 Asia Pacific Obesity Applications Market by Country
6.3.2.6 Asia Pacific CVD Applications Market by Country
6.3.2.7 Asia Pacific Other Applications Market by Country
6.3.3 Asia Pacific Digital Therapeutics Market by Country
6.3.3.1 China Digital Therapeutics Market
6.3.3.1.1 China Digital Therapeutics Market by End Use
6.3.3.1.2 China Digital Therapeutics Market by Applications
6.3.3.2 Japan Digital Therapeutics Market
6.3.3.2.1 Japan Digital Therapeutics Market by End Use
6.3.3.2.2 Japan Digital Therapeutics Market by Applications
6.3.3.3 India Digital Therapeutics Market
6.3.3.3.1 India Digital Therapeutics Market by End Use
6.3.3.3.2 India Digital Therapeutics Market by Applications
6.3.3.4 South Korea Digital Therapeutics Market
6.3.3.4.1 South Korea Digital Therapeutics Market by End Use
6.3.3.4.2 South Korea Digital Therapeutics Market by Applications
6.3.3.5 Singapore Digital Therapeutics Market
6.3.3.5.1 Singapore Digital Therapeutics Market by End Use
6.3.3.5.2 Singapore Digital Therapeutics Market by Applications
6.3.3.6 Malaysia Digital Therapeutics Market
6.3.3.6.1 Malaysia Digital Therapeutics Market by End Use
6.3.3.6.2 Malaysia Digital Therapeutics Market by Applications
6.3.3.7 Rest of Asia Pacific Digital Therapeutics Market
6.3.3.7.1 Rest of Asia Pacific Digital Therapeutics Market by End Use
6.3.3.7.2 Rest of Asia Pacific Digital Therapeutics Market by Applications
6.4 LAMEA Digital Therapeutics Market
6.4.1 LAMEA Digital Therapeutics Market by End Use
6.4.1.1 LAMEA Patients Market by Country
6.4.1.2 LAMEA Providers Market by Country
6.4.1.3 LAMEA Payers Market by Country
6.4.1.4 LAMEA Employers Market by Country
6.4.1.5 LAMEA Other End Use Market by Country
6.4.2 LAMEA Digital Therapeutics Market by Applications
6.4.2.1 LAMEA Diabetes Applications Market by Country
6.4.2.2 LAMEA CNS Disease Applications Market by Country
6.4.2.3 LAMEA Respiratory Diseases Applications Market by Country
6.4.2.4 LAMEA Smoking Cessation Applications Market by Country
6.4.2.5 LAMEA Obesity Applications Market by Country
6.4.2.6 LAMEA CVD Applications Market by Country
6.4.2.7 LAMEA Other Applications Market by Country
6.4.3 LAMEA Digital Therapeutics Market by Country
6.4.3.1 Brazil Digital Therapeutics Market
6.4.3.1.1 Brazil Digital Therapeutics Market by End Use
6.4.3.1.2 Brazil Digital Therapeutics Market by Applications
6.4.3.2 Argentina Digital Therapeutics Market
6.4.3.2.1 Argentina Digital Therapeutics Market by End Use
6.4.3.2.2 Argentina Digital Therapeutics Market by Applications
6.4.3.3 UAE Digital Therapeutics Market
6.4.3.3.1 UAE Digital Therapeutics Market by End Use
6.4.3.3.2 UAE Digital Therapeutics Market by Applications
6.4.3.4 Saudi Arabia Digital Therapeutics Market
6.4.3.4.1 Saudi Arabia Digital Therapeutics Market by End Use
6.4.3.4.2 Saudi Arabia Digital Therapeutics Market by Applications
6.4.3.5 South Africa Digital Therapeutics Market
6.4.3.5.1 South Africa Digital Therapeutics Market by End Use
6.4.3.5.2 South Africa Digital Therapeutics Market by Applications
6.4.3.6 Nigeria Digital Therapeutics Market
6.4.3.6.1 Nigeria Digital Therapeutics Market by End Use
6.4.3.6.2 Nigeria Digital Therapeutics Market by Applications
6.4.3.7 Rest of LAMEA Digital Therapeutics Market
6.4.3.7.1 Rest of LAMEA Digital Therapeutics Market by End Use
6.4.3.7.2 Rest of LAMEA Digital Therapeutics Market by Applications
Chapter 7. Company Profiles
7.1 ResMed, Inc. (Propeller Health)
7.1.1 Company Overview
7.1.1 Financial Analysis
7.1.2 Segmental and Regional Analysis
7.1.3 Research & Development Expense
7.1.4 Recent strategies and developments:
7.1.4.1 Approvals and Trials:
7.1.4.2 Partnerships, Collaborations, and Agreements:
7.2 Teladoc Health, Inc. (Livongo Health)
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Recent strategies and developments:
7.2.3.1 Partnerships, Collaborations, and Agreements:
7.2.3.2 Acquisition and Mergers:
7.3 Noom, Inc.
7.3.1 Company Overview
7.3.2 Recent strategies and developments:
7.3.2.1 Partnerships, Collaborations, and Agreements:
7.4 Omada Health, Inc.
7.4.1 Company Overview
7.4.2 Recent strategies and developments:
7.4.2.1 Partnerships, Collaborations, and Agreements:
7.4.2.2 Acquisition and Mergers:
7.4.2.3 Product Launches and Product Expansions:
7.5 Welldoc, Inc.
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Partnerships, Collaborations, and Agreements:
7.6 Canary Health
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Partnerships, Collaborations, and Agreements:
7.6.2.2 Business Expansions:
7.7 Mango Health, Inc. (TrialCard, Incorporated)
7.7.1 Company Overview
7.7.2 Recent strategies and developments:
7.7.2.1 Partnerships, Collaborations, and Agreements:
7.8 2Morrow, Inc.
7.8.1 Company Overview
7.9 Pear Therapeutics, Inc.
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Partnerships, Collaborations, and Agreements:
7.9.2.2 Acquisition and Mergers:
7.9.2.3 Product Launches and Product Expansions:
7.10. Mindstrong, Inc.
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Partnerships, Collaborations, and Agreements:
Unique Offerings 